Dr. Raphael Bösl

  • Various national and international lectures on intellectual property; IP Newsletters on
  • SPCs and Medical Devices - a decision from the German Federal Patent Court -  Regulation 469/2009 requires a pharmacological, immunological or metabolic action of the product of its own: BPatG Decision 14 W (pat) 45/12 (by Dr. Ulrike Herr and Dr. Raphael Bösl, The SPC Blog, March 11, 2016)
  • "Biotech Directive Prompts Changes to Utility Models", Life Science Law Review, October 2001
  • "Implementing the EU Biotech Directive" in Life Science Contacts Handbook 2001, p. 25, J. Nurton, ed., Mangaging Intellectual Property
  • "Patents - Products - Contracts", World Markets Series, BUSINESS BRIEFING, Pharma Tech, World Markets Research Centre, London, April 1999 (CD-ROM)